Citations

Showing 10 of 108094 citations.

Treatment Aggressiveness for Differentiated Thyroid Cancers Varies Widely and Is Influenced by Physician's Attitude and Local Practice Environment
Toro-Tobón, David , Toro-Tobon, David , Brito, Juan P.

Mayo Clinic

Clinical Thyroidology | October 11, 2022 | Volume: 34 | Issue: 10 | Pages: 450-452

10.1089/ct.2022;34.450-452 Get It

Multiparametric Magnetic Resonance Imaging of the Kidneys: Effects of Regional, Side, and Hydration Variations on Functional Quantifications
Liu, Juan , Li, Chengjie , Yin, Meng , Nie, Lisha, Song, Bin , Yin, Meng , Chen, Jie , Zhang, Zhen

Mayo Clinic

Journal of Magnetic Resonance Imaging | October 11, 2022 | Volume: 57 | Issue: 5 | Pages: 1576-1586

10.1002/jmri.28477 | PMID 36219465 Get It

Background To standardize renal functional magnetic resonance imaging (MRI), it is important to understand the influence of side‐to‐side variation, regional variation within the organ, and hydration states in MRI and to search for variables that are not affected by those variations. Purpose To assess MRI‐based biomarkers for characterizing the kidney in healthy volunteers while considering variations in anatomic factors and hydration states. Study Type Prospective. Subjects Twenty‐five healthy volunteers (15 females and 10 males, median age 25 years). Field Strength/Sequence 3.0 T intravoxel incoherent motion diffusion‐weighted imaging, arterial spinning labeling imaging, blood oxygenation level dependent imaging, and three‐dimensional MR elastography. Assessment Functional variables were measured before and after water challenge. Regions of interest were manually drawn by two investigators (JC and ZZ, with 8‐ and 5‐year experiences in abdominal radiology) in the cortex, the medulla, and the entire kidney. The medulla/cortex ratio was calculated. Statistical Tests Paired t ‐test or Wilcoxon signed rank test; interobserver correlation coefficient; repeatability coefficients; Spearman's correlation; significance level: P < 0.05. Results Diffusion parameters were only subject to regional variation. R2*, RBF, and renal stiffness (RS) showed regional variation, side variation, and dependence on hydration states. For each side and hydration state, the cortex showed significantly higher standard apparent diffusion coefficient (sADC), higher true diffusion ( D ), lower R2*, and lower RS than the medulla. For each region at baseline, the left kidney showed significantly higher R2*, higher RS, and lower renal blood flow (RBF) than the right kidney. For each region and side, RS and RBF increased significantly while R2* decreased significantly after water intake. After introducing the intrinsic regional difference, significantly higher medulla/cortex ratio of RS remained after water intake except for RS@90 Hz in the right kidney. Data Conclusion Renal multiparametric MRI quantifications were affected by regional variation, side variation, and hydration states. Level of Evidence 2 Technical Efficacy Stage 1
Bezold–Jarisch reflex mediated syncope in pulmonary arterial hypertension: An illustrative case series
Agboola, Kolade M. , Kowlgi, Gurukripa N. , DuBrock, Hilary M. , Allison, Thomas G. , DuBrock, Hilary M , Allison, Thomas G , Kowlgi, Narayan G , Csécs, Ibolya , Cajigas, Héctor

Mayo Clinic

Pulmonary Circulation | October 11, 2022 | Volume: 12 | Issue: 4 | Pages: No page available

10.1002/pul2.12147 | PMID 36325510 Get It

AbstractWe present a novel description of Bezold–Jarisch Reflex (BJR) during cardiopulmonary exercise testing (CPET) in three young female patients with Group 1 pulmonary arterial hypertension (PAH). These three cases presented within 26 months, representing only 0.8% of 11,387 tests on patients with PAH undergoing CPET during this time frame.
Letter: Pressure to Publish—A Precarious Precedent Among Medical Students
Jarvis, Nicholas R. , Quiñones‐Hinojosa, Alfredo , Redett, Richard J. , Reece, Edward M., Noland, Shelley S. , Singh, Rohin

Mayo Clinic

Neurosurgery | October 11, 2022 | Volume: 91 | Issue: 6 | Pages: e172-e173

10.1227/neu.0000000000002176 | PMID 36218366 Get It

Managing Spiritual Care Departments During the COVID-19 Pandemic: A Qualitative Study
Muehlhausen, Beth L. , Desjardins, Cate Michelle , Chappelle, Christa , Schwartzman, Gabrielle , Tata, Beba , Fitchett, George , Tata-Mbeng, Beba Shensi

Mayo Clinic

Journal of Pastoral Care & Counseling: Advancing theory and professional practice through scholarly and reflective publicati | October 11, 2022 | Volume: 76 | Issue: 4 | Pages: 294-303

10.1177/15423050221122029 | PMID 36217802 Get It

This qualitative study reports how 20 spiritual care leaders provided leadership in the early months of the COVID-19 pandemic. The patterns and themes that emerged centered around the changing world of chaplaincy, the administrative role of the leader, and the personal story of the leader. Spiritual care leaders demonstrated creativity with the potential to shape chaplaincy in positive ways, expanding the reach of spiritual care.
Ophthalmic adverse effects of BRAF inhibitors
Becerra, Clara M. Castillejo , Smith, Wendy M. , Dalvin, Lauren A. , Castillejo Becerra, Clara M , Dalvin, Lauren A

Mayo Clinic

European Journal of Ophthalmology | October 11, 2022 | Volume: 33 | Issue: 2 | Pages: 1224-1231

10.1177/11206721221132872 | PMID 36217756 Get It

To determine the frequency, characteristics, and clinical course of ophthalmic side effects associated with systemic BRAF inhibitor therapy. Medical records of patients taking BRAF inhibitors for the treatment of systemic malignances at Mayo Clinic, Rochester from 01/01/2010 to 08/30/2021, were retrospectively reviewed. Of 901 patients, 14 (1.6%) patients experienced an ophthalmic side effect. Mean age at presentation of the side effect was 60 years (median 59, range 50–80) and 11 (79%) were male. The most common side effect was uveitis in 7 (50%) patients, followed by dry eye in 4 (29%) patients, and central serous chorioretinopathy in 2 (14%) patients, with singular cases of cranial nerve VI palsy and conjunctival edema. A comparison between individual BRAF inhibitors (vemurafenib vs. dabrafenib vs. encorafenib) revealed that patients taking encorafenib had a shorter interval to any ophthalmic adverse event (mean 55.6 vs. 9.8 vs. 4.0 months, p = 0.03) and were the only patients to experience documented dry eye syndrome (DES) in this series. Outcomes were known in 13 (93%) patients, and ophthalmic adverse effects resolved or were controlled without discontinuing therapy in 10 (77%). Uveitis was successfully treated with topical corticosteroids in 4 patients, while 3 patients with refractory uveitis (2 with panuveitis and 1 with unspecified uveitis) required discontinuation of BRAF inhibitor therapy. Ophthalmic adverse events related to systemic BRAF inhibitor use are rare, with estimated frequency of 1.6%. Most events can be treated with local ophthalmic therapy. BRAF inhibitors provide life-saving therapy, and their discontinuation should be avoided.
Leveraging a pharmacogenomics knowledgebase to formulate a drug response phenotype terminology for genomic medicine
Zhao, Yiqing , Brush, Matthew , Wang, Chen , Wagner, Alex H. , Freimuth, Robert R. , Freimuth, Robert R , Wang, Chen , Wagner, Alex H , Liu, Hongfang

Mayo Clinic

Bioinformatics | October 10, 2022 | Volume: 38 | Issue: 23 | Pages: 5279-5287

10.1093/bioinformatics/btac646 | PMID 36222570 Get It

Abstract Motivation Despite the increasing evidence of utility of genomic medicine in clinical practice, systematically integrating genomic medicine information and knowledge into clinical systems with a high-level of consistency, scalability and computability remains challenging. A comprehensive terminology is required for relevant concepts and the associated knowledge model for representing relationships. In this study, we leveraged PharmGKB, a comprehensive pharmacogenomics (PGx) knowledgebase, to formulate a terminology for drug response phenotypes that can represent relationships between genetic variants and treatments. We evaluated coverage of the terminology through manual review of a randomly selected subset of 200 sentences extracted from genetic reports that contained concepts for ‘Genes and Gene Products’ and ‘Treatments’. Results Results showed that our proposed drug response phenotype terminology could cover 96% of the drug response phenotypes in genetic reports. Among 18 653 sentences that contained both ‘Genes and Gene Products’ and ‘Treatments’, 3011 sentences were able to be mapped to a drug response phenotype in our proposed terminology, among which the most discussed drug response phenotypes were response (994), sensitivity (829) and survival (332). In addition, we were able to re-analyze genetic report context incorporating the proposed terminology and enrich our previously proposed PGx knowledge model to reveal relationships between genetic variants and treatments. In conclusion, we proposed a drug response phenotype terminology that enhanced structured knowledge representation of genomic medicine. Supplementary information Supplementary data are available at Bioinformatics online.
Pregnancy and Crohn’s disease: concerns and assurance of medical therapy
Chowdhury, Reezwana , Kane, Sunanda V.

Mayo Clinic

Gastroenterology Report | October 10, 2022 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1093/gastro/goac055 | PMID 36225722 Get It

Abstract Approximately 50% of patients with inflammatory bowel disease including both Crohn’s disease and ulcerative colitis are female with many being diagnosed and treated during their reproductive years. It is important for women to be in remission prior to and during pregnancy. There have been many advances in the treatment of inflammatory bowel disease, including new therapies. In this review, we summarize the currently approved medications for Crohn’s disease and their safety in pregnancy and postpartum. The totality of evidence suggests that the majority of therapies are low-risk before and during pregnancy, and should be continued to control maternal disease.
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis
Muchtar, Eli , Wisniowski, Brendan , Palladini, Giovanni , Milani, Paolo , Merlini, Giampaolo , Schönland, Stefan , Veelken, Kaya, Hegenbart, Ute , Geyer, Susan M. , Kumar, Shaji , Liedtke, Michaela , Szalat, Raphaël , Landau, Heather , Petrlik, Erica , Lentzsch, Suzanne , Coltoff, Alexander , Bladé, Joan , Cibeira, María Teresa , Cohen, Oliver , Foard, Darren, Wechalekar, Ashutosh , Dispenzieri, Angela , Palladini, Giovanni , Milani, Paolo , Merlini, Giampaolo , Schönland, Stefan , Hegenbart, Ute , Kumar, Shaji K , Kastritis, Efstathios , Dimopoulos, Meletios A , Liedtke, Michaela , Sanchorawala, Vaishali , Landau, Heather , Lentzsch, Suzanne , Gertz, Morie A , Muchtar, E , Szalat, Raphael , Dispenzieri, Angela , Kastritis, Efstathios , Dimopoulos, Meletios Α. , Witteles, Ronald , Wechalekar, Ashutosh D. , Gertz, Morie A.

Mayo Clinic

Journal of Clinical Oncology | October 10, 2022 | Volume: 41 | Issue: 7 | Pages: 1393-1403

10.1200/jco.22.00643 | PMID 36215675 Get It

PURPOSE Binary cardiac response assessment using cardiac biomarkers is prognostic in light chain amyloidosis. Previous studies suggested four-level cardiac responses using N-terminal prohormone of brain natiuretic peptide improves prognostic prediction. This study was designed to validate graded cardiac response criteria using N-terminal prohormone of brain natiuretic peptide/brain natiuretic peptide. PATIENTS AND METHODS This retrospective, multicenter study included patients with light chain amyloidosis who achieved at least a hematologic partial response (PR) and were evaluable for cardiac response. Four response criteria were tested on the basis of natriuretic peptide response depth: cardiac complete response (CarCR), cardiac very good partial response (CarVGPR), cardiac PR (CarPR), and cardiac no response (CarNR). Response was classified as best response and at fixed time points (6, 12, and 24 months from therapy initiation). The study primary outcome was overall survival. RESULTS 651 patients were included. Best CarCR, CarVGPR, CarPR, and CarNR were achieved in 16%, 26.4%, 22.9%, and 34.7% of patients, respectively. Patients in cardiac stage II were more likely to achieve CarCR than patients in cardiac stage IIIA and IIIB (22% v 13.5% v 3.2%; P < .001). A deeper cardiac response was associated with a longer survival (5-year overall survival 93%, 79%, 65%, and 33% for CarCR, CarVGPR, CarPR, and CarNR, respectively; P < .001). Fixed time-point analyses and time-varying covariates Cox regression analysis, to minimize survivorship bias, affirmed the independent survival advantage of deeper cardiac responses. Four-level response performed better than two-level response as early as 12 months from therapy initiation. CONCLUSION Graded cardiac response criteria allow better assessment of cardiac improvement compared with the traditional binary response system. The study re-emphasizes the importance of early diagnosis, which increases the likelihood of deep cardiac responses.